北京天坛生物制品股份有限公司第九届董事会第二十二次会议决议公告

Core Points - The company held its 22nd meeting of the 9th Board of Directors on June 30, 2025, via electronic communication, with all nine directors participating in the vote [1][2] - The board approved the revised "External Donation Management Measures" [1] - The company’s subsidiary, Lanzhou Biological Products Co., Ltd., will donate 800,000 yuan to the Gansu Provincial Health Development Foundation [3][4] - The company’s subsidiary, Nanjing Rouxin Plasma Collection Co., Ltd., will donate 30,000 yuan to the Nanjing Red Cross Society [5][6] - The announcement was made on June 30, 2025 [8]